Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Lawmakers, advocates and insurers debate reference‑based pricing, CON thresholds and drug costs as drivers of Vermont’s expensive health care
Summary
Stakeholders at the House Health Care Committee session discussed reference‑based pricing, certificate‑of‑need thresholds, prescription drug pricing, 340B tracking and market structure as potential levers to control Vermont’s high health care costs.
Stakeholders testifying to the Vermont House Committee on Health Care aired competing policy ideas to address why Vermont has among the highest health care costs in the country: reference‑based pricing, changes to certificate‑of‑need rules, stronger transparency on outpatient drug pricing and attention to market structure that is shifting risk out of state‑regulated markets.
"Reference‑based pricing could help rationalize prices across providers, but you wouldn't want to do it just for one payer or overnight," said Sarah Teachout, director of government and media relations for Blue Cross and Blue Shield of Vermont. Teachout told the committee Blue Cross supports the concept in principle but urged phased implementation and broad application across payers to avoid unintended cost shifting that could jeopardize hospital budgets.
Mike Fisher, the state's Health Care Advocate, urged legislative action to develop a theory for how Vermont will pay for the health care system it wants. Fisher suggested raising the threshold for certificate‑of‑need (CON) review to encourage more competition in some areas, while warning that CON reform requires nuance to…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat

